Brentuximab Vedotin for Treating Relapsed or Refractory...

  • Main
  • 2020 / 3
  • Brentuximab Vedotin for Treating Relapsed or Refractory...

Brentuximab Vedotin for Treating Relapsed or Refractory CD30-Positive Cutaneous T-Cell Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Stainthorpe, Angela, Fleeman, Nigel, Houten, Rachel, Chaplin, Marty, Boland, Angela, Beale, Sophie, Dundar, Yenal, McEntee, Joanne, Syndikus, Isabel
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
PharmacoEconomics - Open
DOI:
10.1007/s41669-020-00203-0
Date:
March, 2020
File:
PDF, 1.07 MB
english, 2020
Conversion to is in progress
Conversion to is failed